Two Sigma Investments LP Has $2.12 Million Holdings in Integer Holdings Co. (NYSE:ITGR)

Two Sigma Investments LP trimmed its holdings in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 62.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 15,957 shares of the medical equipment provider's stock after selling 26,943 shares during the period. Two Sigma Investments LP's holdings in Integer were worth $2,115,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Mather Group LLC. boosted its position in Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 143 shares during the period. Lee Danner & Bass Inc. bought a new stake in Integer in the fourth quarter valued at $27,000. R Squared Ltd bought a new stake in Integer in the fourth quarter valued at $44,000. Sterling Capital Management LLC boosted its holdings in shares of Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock valued at $45,000 after acquiring an additional 279 shares during the period. Finally, Principal Securities Inc. grew its position in shares of Integer by 31.2% during the fourth quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock worth $85,000 after acquiring an additional 152 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on ITGR. Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Truist Financial set a $150.00 price target on Integer and gave the company a "buy" rating in a report on Friday, April 25th. Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and increased their price objective for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Raymond James raised their target price on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, April 25th. Finally, Benchmark reduced their price target on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Integer presently has a consensus rating of "Moderate Buy" and a consensus price target of $145.00.

Insider Buying and Selling

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the sale, the chief executive officer now directly owns 47,000 shares of the company's stock, valued at $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 2.16% of the company's stock.

Integer Price Performance

ITGR traded up $0.66 during trading on Thursday, reaching $120.83. The stock had a trading volume of 296,251 shares, compared to its average volume of 374,886. Integer Holdings Co. has a 1-year low of $104.93 and a 1-year high of $146.36. The firm has a market capitalization of $4.22 billion, a price-to-earnings ratio of 35.96, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03. The stock has a 50 day moving average of $118.69 and a two-hundred day moving average of $128.29. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the business posted $1.14 earnings per share. As a group, equities analysts anticipate that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.